CUV 2.96% $29.84 clinuvel pharmaceuticals limited

epitan - commercialisation contract

  1. 3,567 Posts.
    Just read a analyst report that suggests EPT is talking to large companies in regards to commercialisation and a possible deal. They are assuming a 10% royalty which would probably come along with a placement to the relative company + up front payment. The market size is very large (billions if they can make a cream but even hundreds of millions using the current proven method).

    Given Phase II release in in a few weeks and that the market cap is under 30m it just seems too good to be true??

    Any ideas??

    Thanks,
    Munch
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$29.84
Change
-0.910(2.96%)
Mkt cap ! $1.474B
Open High Low Value Volume
$30.91 $31.50 $29.76 $6.192M 205.5K

Buyers (Bids)

No. Vol. Price($)
3 1337 $29.84
 

Sellers (Offers)

Price($) Vol. No.
$29.85 1630 2
View Market Depth
Last trade - 16.10pm 13/11/2019 (20 minute delay) ?
(live)
Last
$29.86
  Change
-0.910 ( 3.04 %)
Open High Low Volume
$31.49 $31.49 $29.77 14830
Last updated 15.59pm 13/11/2019 (live) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.